How a semi-governmental body became a covert channel for private interests in Dutch health policy—and what it reveals about the fragility of Nordic institutional trust
Executive Summary
In the spring of 2024, Business Sweden—a trade promotion body jointly owned by the Swedish state and industry—hosted a closed-door event at the Dutch Parliament under the title “Navigating Nicotine Regulation: Insights From Sweden.” The stated purpose was to present alternatives to a proposed ban on white snus, a smokeless nicotine product. What the invitation did not disclose, and what Business Sweden has since refused to confirm, was that the event was commissioned by a private, undisclosed company—almost certainly from the tobacco industry.
An investigation by Swedish Radio (Ekot) has laid bare a case study in institutional opacity: a state-affiliated body acting as a lobbying vehicle for concealed commercial interests in a foreign democratic health policy debate. The implications extend far beyond nicotine regulation. They touch on the integrity of Nordic public-private institutions, the erosion of cross-border trust in governance, and the vulnerability of small, open economies to regulatory capture by well-resourced industry actors.
For senior executives, investors, and policymakers, the episode is a cautionary tale about reputational risk, institutional accountability, and the thin line between legitimate trade advocacy and covert influence operations.
The Event: A Carefully Constructed Narrative
In April 2024, Dutch parliamentarians received an invitation from Tomas Korseman, Trade Commissioner at Business Sweden’s office in The Hague. The event promised “insights from Sweden” on nicotine regulation, with speakers including Swedish politicians and opinion leaders who promoted snus as an effective smoking cessation tool—a narrative that aligns closely with the tobacco industry’s “harm reduction” strategy, but one that Sweden’s own Public Health Agency disputes.
What the invitation omitted was material: Business Sweden was not acting on its own initiative. It was executing a private assignment.
“We never come up with ideas ourselves. It is always the companies that come to us,” Korseman admitted to Ekot. When pressed for the client’s identity, he referred inquiries to the communications department and subsequently ceased all communication. Business Sweden’s press team declined interview requests.
In a written statement, the organisation confirmed the assignment originated from a private company and conceded that participants “should have been informed” of this fact. It maintained that the event complied with the WHO Framework Convention on Tobacco Control (FCTC), which mandates transparency in interactions between policymakers and the tobacco industry to prevent covert influence on public health policy.
Yet Ekot’s review of the invitation found no mention of a third-party client. Business Sweden described this omission as merely “unfortunate.”
Today, the organization refuses to name the client, citing confidentiality. When asked directly whether the commissioning company belongs to the tobacco industry, it declined to answer.
The Dutch Reaction: A Foreign Parliament’s Loss of Trust
For Daniëlle Jansen, a former Dutch MP from the Christian Democratic New Social Contract (NSC) party and former Health Minister, the episode represents something more serious than a bureaucratic oversight.
“I see this as an attempt by commercial interests to influence health policy, and it is deeply worrying,” she told Ekot. “I think it is very misleading and undermines independent health policy.”
Her critique carries weight beyond personal indignation. The Netherlands is currently navigating a complex regulatory landscape around nicotine products. White snus—small pouches containing nicotine but no tobacco leaf—has surged in popularity among young people, prompting calls for stricter controls. The Dutch government has been weighing a ban, while the European Union simultaneously revises its Tobacco Excise Directive and prepares an overhaul of the Tobacco Products Directive. In this environment, any attempt to influence parliamentary opinion without full disclosure of commercial backing strikes at the heart of democratic legitimacy.
Jansen’s response also signals a reputational cost for Sweden. When a foreign parliamentarian publicly accuses a Swedish state-linked body of “misleading” conduct, the damage is not confined to a single event. It raises questions about whether Swedish institutions can be instrumentalized by private commercial interests without public oversight—a narrative that sits uncomfortably with the Nordic model of transparent, consensus-driven governance.
The Nordic Context: Six Structural Critiques
Drawing from the principles that have long underpinned Sweden and its Nordic neighbours, several sharp critiques emerge from this episode—each with implications for how state-backed institutions operate in an era of intensifying corporate lobbying.
1. Market Distortion Through State-Enabled Advantage
Nordic economies are built on genuine competition, consumer sovereignty, and a level playing field—not on state-backed entities quietly advancing the interests of concealed private actors. By using Business Sweden as a lobbying channel, an undisclosed company gained access to the prestige, credibility, and diplomatic networks of a state-affiliated body while remaining shielded from public scrutiny.
This is not free-market competition. It is state-enabled advantage for a party that has not earned its place in the policy debate through transparency or merit. For entrepreneurs and investors operating in Nordic markets, the precedent is troubling: it suggests that institutional access can be rented rather than earned.
2. The Erosion of Accountability
Accountability requires traceability. When Business Sweden hides behind “confidentiality” and refuses even to confirm whether its client is a tobacco company, it severs the chain of responsibility that citizens in a democracy have a right to expect.
A public-private hybrid body must meet a higher transparency standard than a purely private firm precisely because it carries the implicit trust of the state and, by extension, the taxpayer. In this case, that trust appears to have been exploited rather than honoured. Swedish citizens funded an institution that, in turn, served an undisclosed foreign commercial agenda in another country’s health policy process.
3. The Nordic Scepticism of Lobbying
In the Nordic political culture, lobbying is often viewed with deep scepticism—not as legitimate advocacy, but as a legally sanctioned form of corruption. The distinction matters little if the outcome is the same: private money covertly steering public policy.
The fact that a health policy decision in the Netherlands was targeted using a Swedish state-backed entity, without full disclosure, validates this scepticism. It transforms lobbying from transparent persuasion into something that looks disturbingly like backchannel influence—an approach more commonly associated with jurisdictions where regulatory capture is routine, not exceptional.
4. Sweden’s Reputational Capital at Risk
Sweden’s global competitiveness rests partly on its reputation for clean governance, ethical international engagement, and institutional reliability. Incidents like this chip away at that foundation. In an era where ESG criteria, institutional integrity, and geopolitical trust increasingly shape investment flows and trade relationships, reputational capital is not an abstract asset—it is a determinant of market access and partnership quality.
When a Swedish state-linked body is accused by a foreign parliamentarian of undermining independent health policy, the narrative extends beyond one event. It suggests that Swedish institutions are available for hire—a proposition that contradicts the very values Sweden promotes abroad.
5. The WHO Convention as Legal Shield, Not Ethical Standard
Business Sweden’s reference to WHO FCTC compliance rings hollow upon examination. The convention demands transparency precisely because the tobacco industry’s history of covert influence on public health policy is extensively documented. Admitting the omission was merely “unfortunate” after being caught suggests the convention was treated as a legal checkbox, not a genuine ethical commitment.
For a country that prides itself on high moral standards in international affairs, this represents a retreat into bureaucratic minimalism. It is the difference between asking “What is the minimum we can disclose?” and “What is the right thing to do?” The latter is the standard Nordic institutions have historically been expected to meet.
6. The “We Just Take Orders” Defence
Perhaps the most troubling aspect of Korseman’s statement—that Business Sweden never initiates ideas, companies always come to them—is what it reveals about institutional autonomy. It suggests a body with no independent ethical filter, functioning as a mercenary service for any private actor with an agenda and a budget.
A body half-owned by the Swedish state should exercise judgment about which causes it advances, particularly when public health and foreign democratic processes are at stake. The absence of such judgment raises fundamental questions about governance: who, if anyone, is exercising oversight over Business Sweden’s client selection? What red-line criteria exist to prevent the organization from being used to advance interests that conflict with Swedish public policy or international health commitments?
The Broader Landscape: Tobacco Lobbying in Europe
The Business Sweden episode did not occur in a vacuum. Across Europe, the tobacco industry has intensified its lobbying efforts as the European Commission advances revisions to the Tobacco Excise Directive and the Tobacco Products Directive. Since June 2024, tobacco lobbyists have held over 220 meetings with Members of the European Parliament, with the European People’s Party, European Conservatives and Reformists, and far-right groups receiving the bulk of attention. Health organizations, by contrast, have held only 39 meetings during the same period—a ratio of roughly five to one.
The industry’s central narrative—”harm reduction” through smoke-free alternatives—has become its primary lobbying strategy. The Commission’s proposal to tax alternative nicotine products similarly to traditional tobacco has drawn fierce industry opposition, with lobbyists arguing that higher taxes remove the incentive for smokers to switch to “less harmful” alternatives.
This context matters for understanding the Business Sweden event. The Dutch Parliament was not a random target; it was a strategic node in a broader European campaign to shape nicotine regulation before the EU’s directive revisions are finalized. By using a state-backed Swedish body as its vehicle, the undisclosed client sought to lend credibility and Nordic authority to an industry talking point—a tactic that would have been far less effective had the commercial backing been transparent.
The Governance Gap: Who Watches the Watchers?
The fundamental question this episode raises is one of institutional design. Business Sweden operates under a hybrid model: jointly owned by the Swedish state and private industry, it is tasked with promoting Swedish exports and attracting foreign investment. This structure gives it access to diplomatic networks, government credibility, and public funding—assets that purely private consultancies cannot match.
But with those privileges come responsibilities that the organization appears ill-equipped to discharge. There is no evidence in the public record of robust internal protocols to screen clients for conflicts with Swedish public health policy, international treaty obligations, or democratic norms in target countries. The “we just take orders” defence suggests the opposite: a culture of client service unmediated by public-interest judgment.
For policymakers, this is a design flaw with systemic implications. As state-backed trade promotion bodies proliferate across Europe—often operating with limited parliamentary oversight—the risk of similar incidents grows. The question is not whether Business Sweden acted illegally; it is whether it acted with the ethical rigor that its public ownership demands.
Conclusion: Redrawing the Line
This episode exposes a tension at the heart of state-backed trade promotion that is neither unique to Sweden nor easily resolved. When does supporting domestic business abroad cross into enabling special-interest manipulation of foreign policy? For a region that values open markets, clean governance, and transparent institutions, the answer should be clear: it crosses that line the moment the client’s identity becomes a secret worth keeping.
For investors and business leaders, the lesson is about reputational risk in an interconnected world. A Swedish institution’s actions in The Hague can erode trust in Swedish governance from Berlin to Brussels. For policymakers, it is a reminder that institutional design must keep pace with the sophistication of corporate influence strategies. And for citizens in both Sweden and the Netherlands, it is a warning that the architecture of democratic accountability is only as strong as its weakest institutional joint.
Business Sweden’s refusal to name its client is not merely a confidentiality decision. It is a choice to privilege a private commercial interest over public transparency—and in doing so, to compromise the integrity of a state-affiliated body and the trust it was built to serve.
Editorial Outlook
Follow-Up Angle: “The Nordic Trade-Promotion Complex: A Comparative Audit of Accountability”
The Business Sweden case invites a broader examination of how Nordic state-backed trade and investment promotion bodies operate across borders. A follow-up article should conduct a comparative audit of Business Sweden, Business Finland, Innovation Norway, and similar institutions to assess:
Client screening protocols: What criteria, if any, exist to prevent these bodies from accepting assignments that conflict with domestic public health policy, international treaty obligations, or democratic norms in target jurisdictions?
Transparency standards: To what extent are client relationships, lobbying activities, and event sponsorships disclosed to host-country policymakers and the public?
Oversight mechanisms: What parliamentary, ministerial, or independent oversight exists to review these bodies’ activities, and how effective is it in practice?
Reputational risk management: How do these institutions weigh short-term commercial gains against long-term damage to national credibility and institutional trust?
Such an audit would speak directly to Nordic Business Journal’s readership of senior executives, investors, and policymakers who depend on these institutions as credible partners in international markets. It would also test whether the Nordic model of governance—often held up as a global benchmark—can withstand the pressures of an era in which corporate influence is increasingly sophisticated, cross-border, and opaque.
This article is published by Nordic Business Journal. We welcome engagement from senior executives, investors, policymakers, and business leaders on the topics raised here.
For further insights, partnership inquiries, editorial feedback, or to discuss this story with our editorial team, please contact us at editorial@nordicbusinessjournal.com. Follow us for ongoing coverage of Nordic governance, institutional integrity, and the intersection of commerce and public policy.
— The Editors